HEALTHBANK HOLDINGS LIMITED (40B) Fair Value & Analysis
Real Estate · SG · Market cap 5.9M SGD
Fair value as of: Aug 13, 2026
From 3 valuation models · updated 4 days ago
Fair value updated Aug 13, 2026, revised from 0.0328 SGD to 0.0360 SGD (+9.9%) since Aug 9, 2026. Share price +31.0% over the past month.
Below-average quality, and screening another 35% overvalued on our models.
What matters now
- The price sits above even our optimistic bull case (0.0360 SGD). The favourable scenario is already priced in.
- Weak quality (35/100) and above fair value at the same time, the margin of safety is missing on both counts.
- The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.
- As a real-estate business, asset- and dividend-based methods carry more weight here than a standard DCF.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.
How to read this chart
60‑month range 0.0290 SGD – 0.2400 SGD · the 0.0550 SGD price screens above the 0.0360 SGD fair value. Dashed = 300-day average. As of Aug 13, 2026.
Analysis
HEALTHBANK HOLDINGS LIMITED (40B) currently trades at 0.0550 SGD, while our model-based Fair Value estimate is 0.0360 SGD, implying the stock looks roughly 34.6% overvalued today. The Quality Score stands at 35/100 (below-average quality), in the Real Estate sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: low).
Trailing-twelve-month revenue stands at 140K SGD. Revenue declined 26.4% year over year. It earns a return on equity of -21.8%. Fundamentals as of Aug 13, 2026
The share trades about 35% below its 52-week high and 104% above its 52-week low, currently below its 200-day average. For context, the median of 10 Real Estate peers we cover trades at 15% fair-value upside, at -35%, 40B screens richer than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 3 models by family
Widest divergence: Dividend Discount (0.0700 SGD) versus Dividend Discount (0.0700 SGD). Highest evidence: Gordon GGM (70).
Notify me when 40B reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 41 · Market factors (momentum, volatility) 33
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
HealthBank Holdings Limited, an investment holding company, engages in the property-related investment and management business in the People's Republic of China, Singapore, and the Asia Pacific Region. It offers landscaping, property, consulting, and facilities management services. The company also provides consulting services as a property advisor.
Full company description
HealthBank Holdings Limited, an investment holding company, engages in the property-related investment and management business in the People's Republic of China, Singapore, and the Asia Pacific Region. It offers landscaping, property, consulting, and facilities management services. The company also provides consulting services as a property advisor. The company was formerly known as SMJ International Holdings Ltd. and changed its name to HealthBank Holdings Limited in April 2019. HealthBank Holdings Limited was incorporated in 2013 and is headquartered in Singapore.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
HEALTHBANK HOLDINGS LIMITED reported revenue of 140K SGD in FY2025 versus 99.0K SGD in FY2021, a compound +9.0%/yr. Reported net income was −3.2M SGD in FY2025.
40B screens 35% overvalued. Compare with Plaza S.A →
Peer Group
Real Estate Services · 530 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Real Estate Services median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
VALUE 0: the price sits above our fair-value range.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Real Estate Services stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Plaza S.A MALLPLAZA | 3,989 CLP | 4,571 CLP | +15% |
| PT Solusi Tunas Pratama Tbk SUPR | 43,850 IDR | 15,049 IDR | -66% |
| Cencosud Shopping S.A CENCOMALLS | 2,412 CLP | 2,976 CLP | +23% |
| PT Sarana Menara Nusantara Tbk. owns and TOWR | 392.00 IDR | 1,012 IDR | +158% |
| PT Metropolitan Kentjana Tbk MKPI | 22,000 IDR | 19,160 IDR | -13% |
| PT Bangun Kosambi Sukses Tbk, CBDK | 3,610 IDR | 3,464 IDR | -4% |
| IRSA Inversiones y Representaciones Sociedad Anónima, IRSA | 2,495 ARS | 2,990 ARS | +20% |
| PT Plaza Indonesia Realty Tbk PLIN | 2,510 IDR | 2,698 IDR | +7% |
| PT MNC Tourism Indonesia Tbk, KPIG | 74.00 IDR | 122.12 IDR | +65% |
| PT Indonesian Paradise Property Tbk INPP | 770.00 IDR | 291.52 IDR | -62% |
Compare HEALTHBANK HOLDINGS LIMITED with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Real Estate stocks →
Frequently asked questions
Is HEALTHBANK HOLDINGS LIMITED (40B) overvalued or undervalued?
What is the fair value of 40B?
What is the quality score of 40B?
What is the revenue of HEALTHBANK HOLDINGS LIMITED (40B)?
What is the net profit margin of 40B?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track HEALTHBANK HOLDINGS LIMITED and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.